These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 25684438

  • 1. Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.
    Keyes M, Pickles T, Crook J, McKenzie M, Cheung A, Spadinger I, LaPointe V, Bachand WF, Morris J.
    Brachytherapy; 2015; 14(3):334-41. PubMed ID: 25684438
    [Abstract] [Full Text] [Related]

  • 2. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM, Stock RG, Buckstein M, Stone NN.
    BJU Int; 2012 Jul; 110(2):221-5. PubMed ID: 22734475
    [Abstract] [Full Text] [Related]

  • 3. Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer.
    Ong WL, Hindson BR, Beaufort C, Pharoah P, Millar JL.
    Radiother Oncol; 2014 Jul; 112(1):72-6. PubMed ID: 25086852
    [Abstract] [Full Text] [Related]

  • 4. Erectile function after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):893-902. PubMed ID: 11958881
    [Abstract] [Full Text] [Related]

  • 5. Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: outcome and toxicity.
    Yamada Y, Masui K, Iwata T, Naitoh Y, Yamada K, Miki T, Okihara K.
    Brachytherapy; 2015 Mar 15; 14(2):118-23. PubMed ID: 25304650
    [Abstract] [Full Text] [Related]

  • 6. Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with 125I low dose rate brachytherapy for localized prostate cancer.
    Chasseray M, Dissaux G, Bourbonne V, Boussion N, Goasduff G, Malloreau J, Malhaire JP, Fournier G, Tissot V, Pradier O, Valeri A, Schick U.
    Acta Oncol; 2019 Jul 15; 58(7):1029-1035. PubMed ID: 30761939
    [Abstract] [Full Text] [Related]

  • 7. Erectile function after prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):437-47. PubMed ID: 15890585
    [Abstract] [Full Text] [Related]

  • 8. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
    Macdonald AG, Keyes M, Kruk A, Duncan G, Moravan V, Morris WJ.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):155-63. PubMed ID: 16111584
    [Abstract] [Full Text] [Related]

  • 9. Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancer.
    Bazinet A, Zorn KC, Taussky D, Delouya G, Liberman D.
    Brachytherapy; 2020 Sep 01; 19(2):222-227. PubMed ID: 31837989
    [Abstract] [Full Text] [Related]

  • 10. [Erectile dysfunction evaluation after brachytherapy for low risk prostate adenocarcinoma: prospective study of patients with a baseline IIEF5>16].
    Delage F, Perrouin-Verbe MA, Le Fur E, Papin G, Thoulouzan M, Malhaire JP, Pradier O, Fournier G, Valéri A.
    Prog Urol; 2015 Feb 01; 25(2):68-74. PubMed ID: 25497176
    [Abstract] [Full Text] [Related]

  • 11. The effect on erectile function of 103palladium implantation for localized prostate cancer.
    Ponholzer A, Oismüller R, Somay C, Büchler F, Maier U, Hawliczek R, Rauchenwald M, Madersbacher S.
    BJU Int; 2005 Apr 01; 95(6):847-50. PubMed ID: 15794796
    [Abstract] [Full Text] [Related]

  • 12. Erectile function durability following permanent prostate brachytherapy.
    Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, Anderson R, Lief JH.
    Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):639-48. PubMed ID: 19303721
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of Baseline Erectile Dysfunction (ED) in an Australian Cohort of Men with Localized Prostate Cancer.
    Ong WL, McLachlan H, Millar JL.
    J Sex Med; 2015 May 01; 12(5):1267-74. PubMed ID: 25847707
    [Abstract] [Full Text] [Related]

  • 14. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years.
    Stone NN, Stock RG.
    Urology; 2007 Feb 01; 69(2):338-42. PubMed ID: 17320674
    [Abstract] [Full Text] [Related]

  • 15. Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
    Peng LC, Mian OY, Lakshminarayanan P, Huang P, Bae HJ, Robertson S, Habtu T, Narang A, Agarwal S, Greco S, Tran P, McNutt T, DeWeese TL, Song DY.
    Urology; 2020 Jan 01; 135():111-116. PubMed ID: 31454660
    [Abstract] [Full Text] [Related]

  • 16. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Solan AN, Cesaretti JA, Stone NN, Stock RG.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1468-74. PubMed ID: 18922652
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS, Butler WM, Dorsey AT, Lief JH, Donzella JG.
    Int J Radiat Oncol Biol Phys; 2000 Nov 01; 48(4):1069-74. PubMed ID: 11072164
    [Abstract] [Full Text] [Related]

  • 19. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS, Wallner K, Butler WM, Galbreath RW, Lief JH, Benson ML.
    Int J Radiat Oncol Biol Phys; 2001 Jul 01; 50(3):597-604. PubMed ID: 11395225
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.